CVE-2022-4616

CVE-2022-4616 is a high-severity vulnerability in Deltaww Dx-3021l9 Firmware with a CVSS 3.x base score of 7.2. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-77.

Key facts

Description

The webserver in Delta DX-3021 versions prior to 1.24 is vulnerable to command injection through the network diagnosis page. This vulnerability could allow a remote unauthenticated user to add files, delete files, and change file permissions.

Frequently asked questions

What is CVE-2022-4616?
The webserver in Delta DX-3021 versions prior to 1.24 is vulnerable to command injection through the network diagnosis page. This vulnerability could allow a remote unauthenticated user to add files, delete files, and change file permissions.
How severe is CVE-2022-4616?
CVE-2022-4616 has a CVSS 3.x base score of 7.2, rated high severity. It is exploitable over network with low attack complexity, requires high privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2022-4616 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 5% (91st percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2022-4616?
CVE-2022-4616 affects Deltaww Dx-3021l9 Firmware. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2022-4616?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2022-4616 published?
CVE-2022-4616 was published on 2023-01-13 and last updated on 2026-06-17.

References

Affected products (1)

Other CWE-77 (Command Injection) vulnerabilities

Browse all CWE-77 (Command Injection) vulnerabilities →